Thanks to our state-of-the-art facilities, we perform bacterial and viral infection models from BSL-2 to BSL-3 levels, including SARS-CoV-2, Influenza H1N1, multidrug resistant bacteria from the KAPE group, S. aureus.
We have experience in a wide range of infection routes: sepsis, lung, wound and implant-associated infections (osteoarticular implant, subcutaneous mesh, central venous catheter), in a variety of species: mouse, rat, hamster, chick, ferret and cotton rat.
For testing your vaccine and antiviral/antibacterial therapies, our team has expertise in a wide range of treatment routes from i.v., i.p., s.c., i.m. i.n., and i.t. to endotracheal aerosolization.
We are expert in microbiological readouts (PFU, CFU count, RT-qPCR), inflammatory readouts (flow cytometry, luminex, RT-qPCR) and non-invasive in vivo imaging (bioluminescence) to follow bacterial/viral load longitudinally, reducing the number of animals used as well as saving time and costs.
We are proud of our commitment to provide the most relevant models to fight against emerging pathogens:
